NCT01116063View on ClinicalTrials.gov

Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)

PHASE4UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Inhaled iloprost

Inhalation Initial: 2.5 mcg/dose; if tolerated, increase to 5 mcg/dose; administer 6 times daily

Trial Locations (1)

Unknown

Pulmoanry Division, Carmel Medical Center, Haifa

Sponsors
All Listed Sponsors
lead

Carmel Medical Center

OTHER

NCT01116063 - Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter